Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gigaxonin as a prognistic marker of human cancer

ABSTRACT: Gigaxonin as a prognistic marker of human cancer

PROVIDER: PRJNA743670 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15037958_1.fastq.gz	Fastqsanger.gz
	SRR15037958_2.fastq.gz	Fastqsanger.gz
	SRR15037959_1.fastq.gz	Fastqsanger.gz
	SRR15037959_2.fastq.gz	Fastqsanger.gz
	SRR15037960_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Diagnostic marker for lung cancer through microarray analysis

Project description:Dr. Kate Olson's Lab is interested to expand these analysis to comparisons between human normal lung tissue and human lung tumor tissue. In hopes that this will help in finding a diagnostic marker for lung cancer. Since there will be more variability between these samples, we would like to get preliminary data on ten normal lung tissue and ten lung tumor tissues from the same patient. We have already analyzed 4 cell lines and we saw gene expression variability related to how metastatic the cell lines were. This has been written and submitted for publication. We would like to expand these analysis to comparisons between human normal lung tissue and human lung tumor tissue. We hope that this will help in finding a diagnostic marker for lung cancer. Since there will be more variability between these samples, we would like to get preliminary data on ten normal lung tissue and ten lung tumor tissues from the same patient. The samples were dissected by a pathologist prior to extraction to maximize the amount of normal tissue included in the tumor samples. RNA samples from non tumor and tumor lung cancer patients were received by Core E. The RNA was amplified, labeled, and hybridized to the GLYCOv3 microarrays.

2011-06-14 | E-GEOD-29927 | biostudies-arrayexpress

Diagnostic marker for lung cancer through microarray analysis

2011-06-14 | GSE29927 | GEO

Search for a novel diagnostic marker for liver cancer.

Project description:Search for a novel diagnostic marker for liver cancer.

| PRJNA668068 | ENA

Search for a novel diagnostic marker for liver cancer.

Project description:Search for a novel diagnostic marker for liver cancer.

| PRJNA481878 | ENA

Identification and characterization of new pancreatic cancer stem cells marker

Project description:Identification and characterization of new pancreatic cancer stem cells marker

| PRJNA722871 | ENA

Search for a novel diagnostic marker for liver cancer.

Project description:Analysis of the gene expression proﬁles of tumor and normal tissue samples from Hepatocellular carcinoma (HCC). Find potential secretory protein to serve as diagnostic marker for liver cancer.

2019-04-02 | GSE117361 | GEO

Search for a novel diagnostic marker for liver cancer.

Project description:Analysis of the circular RNA expression proﬁles of tumor and normal tissue samples from Hepatocellular carcinoma (HCC).Find potential circular RNA to serve as diagnostic marker for liver cancer.

2020-10-09 | GSE159220 | GEO

MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma

Project description:The aim of our study was to discover a miR marker panel prognostic of 5-year survival in OSCC patients that may be utilized in parallel with the current clinical covariates. We assessed differential expression of miRNAs genome-wide via deep sequencing in 20 tumor tissue samples. We also attempted to identify deregulated miR expression signatures that may serve as the prognostic marker of cancer survival. Selected miR marker-based panel then may serve as a guide for selection of appropriate follow-up chemo/radiation treatment, significantly improving the clinical management of OSCC and the overall survival rate.

2014-10-21 | GSE52633 | GEO

Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker

Project description:Background: Isolation and characterization of tumourigenic colon cancer initiating cells may help to develop novel diagnostic and therapeutic procedures. Methods: We characterized a panel of fourteen human colon carcinoma cell lines and their corresponding xenografts for the surface expression of different potential stem cell markers: CD133, CD24, CD44, CDCP1 and CXCR4. In five cell lines and nine xenografts mRNA expression of the investigated markers was determined. Tumour growth behaviour of CD133+, CD133- and unsorted SW620 cells was evaluated in vivo. Results: All surface markers showed distinct expression patterns in the examined tumours. Analyses of the corresponding xenografts revealed a significant reduction of cell numbers expressing the investigated markers. CD44 and CXCR4 mRNA expression correlated within the cell line panel and CD44 and CDCP1 within the xenograft panel, respectively. Small subpopulations of double and triple positive cells could be described. SW620 showed significantly higher take rates and shorter doubling times in vivo when sorted for CD133 positivity. Conclusion: Our data support the hypothesis of a small subset of cells with stem cell-like properties characterized by a distinct surface marker profile. In vivo growth kinetics give strong relevance for an important role of CD133 within the mentioned surface marker profile. Key words: colon cancer, tumour stem cell, CD133 Affymetrix® HG-U133 Plus 2.0 mRNA expression arrays were used to determine the expression. CEL result files were pre-processed using the gc-RMA (Zhijin Wu and Rafael A, 2004) algorithm. This microarray analysis was performed for a distinct colon cancer panel including 9 of the 11 xenografts evaluated for stem cell marker expression and 5 of the above mentioned cell lines.

2012-02-02 | E-GEOD-35478 | biostudies-arrayexpress

Cell-free DNA 5-hydroxymethylcytosine as a marker for common cancer detection

Project description:Cell-free DNA 5-hydroxymethylcytosine as a marker for common cancer detection

| PRJNA837976 | ENA